IMR Press / JIN / Volume 22 / Issue 4 / DOI: 10.31083/j.jin2204086
Open Access Review
The Role of Impaired Mitochondrial Transport in the Development of Neurodegenerative Diseases
Show Less
1 Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
2 Petrovsky Scientific Center of Surgery, 119991 Moscow, Russia
3 Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 109240 Moscow, Russia
4 Department of Cardiac Surgery, Moscow Regional Research and Clinical Institute (MONIKI), 129110 Moscow, Russia
*Correspondence: al.blagov2014@gmail.com (Alexander Blagov); alexandernikolaevichorekhov@gmail.com (Alexander Orekhov)
J. Integr. Neurosci. 2023, 22(4), 86; https://doi.org/10.31083/j.jin2204086
Submitted: 15 March 2023 | Revised: 13 April 2023 | Accepted: 18 April 2023 | Published: 3 July 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

The fight against neurodegenerative diseases is one of the key direction of modern medicine. Unfortunately, the difficulties in understanding the factors underlying the development of neurodegeneration hinder the development of breakthrough therapeutics that can stop or at least greatly slow down the progression of these diseases. In this review, it is considered the disruption of mitochondrial transport as one of the pathogenesis factors contributing to neurodegeneration using the examples of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. Here, the mechanism of mitochondrial transport under normal conditions and the mechanisms of disturbances for the indicated diseases will be considered.

Keywords
neurodegenerative diseases
Alzheimer's disease
Parkinson's disease
mitochondrial transport
mitochondria
Funding
23-25-00237/Russian Science Foundation
Figures
Fig. 1.
Share
Back to top